| Lightcalls.com |
|
|
![]() |
In all assurance engagements, clien...In all assurance engagements, client representations are an integral part of the auditors' collection of support and evidence for their reports. if it be not that what if no work is done to substantiate client representations and they turn round out to be false? Well, a member earns into serious trouble, that's what. This fictionalized account is based loosely in succession an actual case before the Professional direction Enquiry Committee (PCEC). Names and circumstances have been changed to keep anonymity. The situation The shareholders of Hi-Flyer, a company that designs and markets digital imaging software, wanted to take their company public. in the same manner they hired Paul, a CA, to provide them with the company's first audited financial statements. Unfortunately, Paul early encountered problems. First, he came across an equipment purchase invoice that appeared to have been altered. To confirm his suspicion, Paul contacted the vendor, who acknowledged that the invoice existed if it be not that claimed it was for a different amount. Alarmed, Paul considered closely at other equipment purchases and discovered that brace suppliers did not even exist. In each case, the equipment described was forward hand, but Paul had to question whether Hi-Flyer had profitable title. And who, he inquiring surpriseed had fabricated and/or altered its equipment invoices? What happened Paul detailed his make uneasys to the company's board of directors. In answer they fired him. Since Hi-Flyer still stand in want ofed audited state44-ments, Hal, the company's CEO hired Ron another CA, to completed the first audit. During the audit, staff members told Ron that another CA had lately been doing "audit-type" work at Hi-Flyer. Ron then noticed that the invoice for a payment to Paul was missing. He threatened Hal about both issues. Hal lied and said Paul had solely worked as a consultant. He also said Paul had been paid a retainer in a less degree than a verbal arrangement, and that no invoices or further payments had been made because Paul had been fired. Hal conclud at telling Ron that Paul was difficult to contact and advised him not to waste time ttying to track Paul down. Ron accepted Hal's explanations, and did not look for any corroborating evidence from Paul. He finished the audit and issued an unqualified audit opinion. The public offering was a succes however the new investors insisted onward hiring their own auditors. Not surprisingly, the of recent origin auditors were not happy with several areas of Ron's work, including his lack of communication with Paul. They contacted Paul, who was amazed to learn of Ron's clear audit opinion in succession the same financial statements that had caused him with equal reason much concern. Paul advised the novel auditors of his letter to Hi-Flyer's board. He also informed the Institute of his recently made known concerns. The outcome In his rejoinder to the PCEC, Ron asserted his decision to trust Hal's explanations without seeking corroboration from Paul. Ron argued that generally accepted auditing standards entitled him to rely forward Hal's representations. The PCEC disagreed. It stated that since Ron had been apprised of a compeer CA's previous "audit-type work," and given that Paul's invoice was missing, Ron should have contacted Paul to at least confirm the mark of work he'd done for Hi-Flyer. It disturbed the PCEC that Ron whose practice included substantial assurance work, strike one as beinged to view client representations as beyond challenge. Also disturbing: Ron did not appear to understand that Rule 3021 was designed to cover him in this kind of scenario, not a third party like Paul. Rule 3021 states that, "A member shall not accept an engagement with notice to the practice of public accounting or the public practice of a function not inconsistent with public accounting, where he is replacing another member or another accountant recognized by way of statutory authority in British Columbia, without first communicating with as it was person and enquiring whether there are any circumstances the member should take into account which might influence the member's decision whether or not to accept the engagement." Clearly, Paul's perspective would have affected Ron's decision to accept the Hi-Flyer engagement. The PCEC determined that Ron had breached conducts of Professional Conduct 201.1 (Reputation of the Profession); 202 (Integrity and to be ascribed Care); 205 (a) (False and Misleading Documents); 206 (Compliance with Professional Standards); and 3021 (Communication with Predecessor). The PCEC approveed that Ron pay costs and a $5000 fine; increase his professional liability insurance; and engage a tutor for all assurance engagements. It also make acceptableed that he not accept any public company audits for at least sum of two units years. Ron accepted the determination and recommendation. The message Additional work must always be done to confirm client representations. No matter by what mode plausible these representations may appear to be you must always exercise your professional skepticism, and obtain sufficient and appropriate audit evidence. And if management's advantageous faith is brought into question, you must re-evaluate your engagement. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |